Adverse events following transcatheter aortic valve implantation (TAVI) in patients with amyloidosis: observations from a global federated network.

Back

ESC Premium Access

Adverse events following transcatheter aortic valve implantation (TAVI) in patients with amyloidosis: observations from a global federated network.

Session: TAVI: aortic stenosis and beyond

Topic: Prosthetic Heart Valves

Speaker: Doctor L. Gerra (Modena, IT)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Luigi Gerra

Modena Polyclinic Modena University Hospital, Modena (Italy)

0 follower

5 more presentations in this session

A propensity score matched analysis of transcatheter aortic valve replacement in failed bioprosthetic valves

Speaker: Doctor K. Loew (Munich, DE)

Predictors for mitral regurgitation improvement in patients with pure severe aortic regurgitation undergoing transcatheter aortic valve replacement: when can kill two birds with one stone?

Speaker: Doctor D. Lin (Shanghai, CN)

Safety and efficacy of transcatheter aortic valve implantation (TAVI) for pure aortic regurgitation; a systematic review and meta-analysis

Speaker: Doctor N. Ktenopoulos (Athens, GR)

Association of cardiac amyloidosis with periprocedural complications in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis

Speaker: Doctor T. Figueira (Stony Brook, US)

Long-term outcomes of aortic stenosis patients with different flow/gradient patterns undergoing transcatheter aortic valve implantation

Speaker: Doctor N. Ktenopoulos (Athens, GR)

Access the full session

TAVI: aortic stenosis and beyond

Speakers: Doctor L. Gerra, Doctor K. Loew, Doctor D. Lin, Doctor N. Ktenopoulos, Doctor T. Figueira...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources